CYP1A1 and liver cancer: Despite BAI being an AHR agonist and upregulating CYP1A1 expression in human HepG2 liver cancer cells [56], it paradoxically reduces the AHR-mediated CYP1A1 expression induced by 7,12-dimethylbenz[a]anthracene (DMBA) [57].